Hemophilia A&B

It's the most common type of bleed for people with hemophilia.

Data collection can help push researchers to new discoveries.

Careful monitoring and prompt treatment are essential.

Annual inhibitor testing isn’t only necessary for very young children with severe hemophilia A, the highest-risk patients, anymore. In fact...

The study reveals quality-of-life issues for people affected by hemophilia B.

The comprehensive care model is ideal for people with hemophilia.

These guidelines help ensure patients with hemophilia receive the right care, delivered in the right way.

The goal of the study is to collect useful data that can improve lives.

This discovery has implications for future gene therapy experiments.

“I wish my son just had plain old hemophilia again,” a mother of one of my inhibitor patients said.

Progress. For years, the bleeding disorders community has been waiting for meaningful progress for a greater understanding of hemophilia, for...

For the past 10 years, people with hemophilia and their family members and caregivers have come together for a three-day...